Skip to content

uniQure QURE Amortization Of Debt Discount Premium

Amortization Of Debt Discount Premium at other companies

Beam Therapeutics logo
Beam TherapeuticsBEAM

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's amortization of debt discount premium.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's amortization of debt discount premium?
uniQure (QURE) reported amortization of debt discount premium of -$4.34M in Q1 2026.
How has uniQure's amortization of debt discount premium changed year-over-year?
uniQure's amortization of debt discount premium decreased by 104.8% year-over-year, from -$2.12M to -$4.34M.
What is the long-term trend for uniQure's amortization of debt discount premium?
Over 2 years (2023 to 2025), uniQure's amortization of debt discount premium has grown at a -2.1% compound annual growth rate (CAGR), from -$10.92M to -$10.46M.